Literature DB >> 9745443

Linkage analysis of candidate genes in autoimmune thyroid disease. II. Selected gender-related genes and the X-chromosome. International Consortium for the Genetics of Autoimmune Thyroid Disease.

G Barbesino1, Y Tomer, E S Concepcion, T F Davies, D A Greenberg.   

Abstract

Hashimoto's thyroiditis (HT) and Graves' disease (GD) are autoimmune thyroid diseases (AITD) in which multiple genetic factors are suspected to play an important role. Until now, only a few minor risk factors for these diseases have been identified. Susceptibility seems to be stronger in women, pointing toward a possible role for genes related to sex steroid action or mechanisms related to genes on the X-chromosome. We have studied a total of 45 multiplex families, each containing at least 2 members affected with either GD (55 patients) or HT (72 patients), and used linkage analysis to target as candidate susceptibility loci genes involved in estrogen activity, such as the estrogen receptor alpha and beta and the aromatase genes. We then screened the entire X-chromosome using a set of polymorphic microsatellite markers spanning the whole chromosome. We found a region of the X-chromosome (Xq21.33-22) giving positive logarithm of odds (LOD) scores and then reanalyzed this area with dense markers in a multipoint analysis. Our results excluded linkage to the estrogen receptor alpha and aromatase genes when either the patients with GD only, those with HT only, or those with any AITD were considered as affected. Linkage to the estrogen receptor beta could not be totally ruled out, partly due to incomplete mapping information for the gene itself at this time. The X-chromosome data revealed consistently positive LOD scores (maximum of 1.88 for marker DXS8020 and GD patients) when either definition of affectedness was considered. Analysis of the family data using a multipoint analysis with eight closely linked markers generated LOD scores suggestive of linkage to GD in a chromosomal area (Xq21.33-22) extending for about 6 cM and encompassing four markers. The maximum LOD score (2.5) occurred at DXS8020. In conclusion, we ruled out a major role for estrogen receptor alpha and the aromatase genes in the genetic predisposition to AITD. Estrogen receptor beta remains a candidate locus. We found a locus on Xq21.33-22 linked to GD that may help to explain the female predisposition to GD. Confirmation of these data in HT may require study of an extended number of families because of possible heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9745443     DOI: 10.1210/jcem.83.9.5091

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients.

Authors:  Takashi Akamizu; Hitomi Hiratani; Satoshi Ikegami; Stephen S Rich; Donald W Bowden
Journal:  J Hum Genet       Date:  2003-04-09       Impact factor: 3.172

2.  Evidence for sex-specific risk alleles in autism spectrum disorder.

Authors:  Jennifer L Stone; Barry Merriman; Rita M Cantor; Amanda L Yonan; T Conrad Gilliam; Daniel H Geschwind; Stanley F Nelson
Journal:  Am J Hum Genet       Date:  2004-10-05       Impact factor: 11.025

Review 3.  X-linked clonality testing: interpretation and limitations.

Authors:  George L Chen; Josef T Prchal
Journal:  Blood       Date:  2007-04-13       Impact factor: 22.113

4.  The relationship between skewed X chromosome inactivation and the prognosis of Graves' and Hashimoto's diseases.

Authors:  Naoko Ishido; Naoya Inoue; Mikio Watanabe; Yoh Hidaka; Yoshinori Iwatani
Journal:  Thyroid       Date:  2014-12-10       Impact factor: 6.568

Review 5.  Role of genetic and non-genetic factors in the etiology of Graves' disease.

Authors:  M Marinò; F Latrofa; F Menconi; L Chiovato; P Vitti
Journal:  J Endocrinol Invest       Date:  2014-11-25       Impact factor: 4.256

6.  An immune defect causing dominant chronic mucocutaneous candidiasis and thyroid disease maps to chromosome 2p in a single family.

Authors:  T P Atkinson; A A Schäffer; B Grimbacher; H W Schroeder; C Woellner; C S Zerbe; J M Puck
Journal:  Am J Hum Genet       Date:  2001-08-21       Impact factor: 11.025

Review 7.  Interferon alpha treatment and thyroid dysfunction.

Authors:  Yaron Tomer; Jason T Blackard; Nagako Akeno
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

8.  Preliminary evidence of a noncausal association between the X-chromosome inactivation pattern and thyroid autoimmunity: a twin study.

Authors:  Thomas Heiberg Brix; Pia Skov Hansen; Kirsten Ohm Kyvik; Laszlo Hegedüs
Journal:  Eur J Hum Genet       Date:  2009-09-30       Impact factor: 4.246

9.  A new Graves disease-susceptibility locus maps to chromosome 20q11.2. International Consortium for the Genetics of Autoimmune Thyroid Disease.

Authors:  Y Tomer; G Barbesino; D A Greenberg; E Concepcion; T F Davies
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

10.  Diffuse thyroid uptake incidentally found on 18F-fluorodeoxyglucose positron emission tomography in subjects without cancer history.

Authors:  Ji Young Lee; Joon Young Choi; Yoon-Ho Choi; Seung Hyup Hyun; Seung Hwan Moon; Su Jin Jang; Yearn Seong Choe; Kyung-Han Lee; Byung-Tae Kim
Journal:  Korean J Radiol       Date:  2013-05-02       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.